Literature DB >> 8289103

Patient preferences for novel therapy: an N-of-1 trial of garlic in the treatment for hypertension.

C A Estrada1, M J Young.   

Abstract

The authors used the N-of-1 clinical trial methodology to obtain insights about a patient's preference for garlic for the management of his hypertension. The 61-year-old man received garlic, 500 mg by mouth three times a day (3 weeks), or identical placebo (3 weeks) in three treatment pairs. While the patient was taking garlic the mean systolic blood pressure decreased by 2 mm Hg (95% confidence interval 0.4 to 4.7, p < 0.05), and the diastolic blood pressure decreased by 2.4 mm Hg (95% confidence interval 0.4 to 4, p < 0.025). The treatment effect of garlic was small, but the patient believed continuing garlic for the management of his hypertension was justified.

Entities:  

Mesh:

Year:  1993        PMID: 8289103     DOI: 10.1007/BF02599719

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  12 in total

1.  Therapy with garlic: results of a placebo-controlled, double-blind study.

Authors:  G Vorberg; B Schneider
Journal:  Br J Clin Pract Suppl       Date:  1990-08

2.  The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.

Authors:  G H Guyatt; J L Keller; R Jaeschke; D Rosenbloom; J D Adachi; M T Newhouse
Journal:  Ann Intern Med       Date:  1990-02-15       Impact factor: 25.391

3.  Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia.

Authors:  J Harenberg; C Giese; R Zimmermann
Journal:  Atherosclerosis       Date:  1988-12       Impact factor: 5.162

4.  Single case studies in clinical trials.

Authors:  G Lindberg
Journal:  Scand J Gastroenterol Suppl       Date:  1988

5.  How decisions are reached: physician and patient.

Authors:  S A Eraker; P Politser
Journal:  Ann Intern Med       Date:  1982-08       Impact factor: 25.391

6.  Hypertension and hyperlipidaemia: garlic helps in mild cases.

Authors:  W Auer; A Eiber; E Hertkorn; E Hoehfeld; U Koehrle; A Lorenz; F Mader; W Merx; G Otto; B Schmid-Otto
Journal:  Br J Clin Pract Suppl       Date:  1990-08

7.  Determining optimal therapy--randomized trials in individual patients.

Authors:  G Guyatt; D Sackett; D W Taylor; J Chong; R Roberts; S Pugsley
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

8.  A clinician's guide for conducting randomized trials in individual patients.

Authors:  G Guyatt; D Sackett; J Adachi; R Roberts; J Chong; D Rosenbloom; J Keller
Journal:  CMAJ       Date:  1988-09-15       Impact factor: 8.262

9.  Patients' rights in decision making: the case for personalism versus paternalism in health care.

Authors:  W S Schain
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

10.  Single case studies. An introduction.

Authors:  H R Wulff
Journal:  Scand J Gastroenterol Suppl       Date:  1988
View more
  2 in total

1.  Increasing the Precision of Hypertension Treatment Through Personalized Trials: a Pilot Study.

Authors:  Ian M Kronish; Ying Kuen Cheung; Daichi Shimbo; Jacob Julian; Benjamin Gallagher; Faith Parsons; Karina W Davidson
Journal:  J Gen Intern Med       Date:  2019-03-11       Impact factor: 5.128

2.  Should we reconsider the routine use of placebo controls in clinical research?

Authors:  Andrew L Avins; Daniel C Cherkin; Karen J Sherman; Harley Goldberg; Alice Pressman
Journal:  Trials       Date:  2012-04-27       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.